The PPFIA4 protein liprin-α4 is involved in the MAPK signalling pathway [44] which may cause castration-resistant PCa through AR pathway independence [45, 46], and has been proposed as a potential therapeutic target for several cancer types [47, 48]. Here, PPFIA4 is linked to cancer.